.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
Express Scripts
Teva
Chubb
Medtronic
Merck
Julphar
McKinsey
Colorcon

Generated: September 26, 2017

DrugPatentWatch Database Preview

Promethazine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for promethazine hydrochloride and what is the scope of promethazine hydrochloride patent protection?

Promethazine hydrochloride
is the generic ingredient in thirteen branded drugs marketed by Perrigo New York, Polymedica, Watson Labs, Taro, Ivax Sub Teva Pharms, Able, Teva, West-ward Pharms Int, Kvk Tech, Cenci, Impax Labs, Pvt Form, Luitpold, Pharm Assoc, Abbott, Prinston Inc, Bedford Labs, Mylan Pharms Inc, Hi Tech Pharma, Tablicaps, G And W Labs, Sandoz, Delcor Asset Corp, X-gen Pharms, Hospira, Vintage, Lannett, Actavis Mid Atlantic, Wockhardt, Teva Pharms Usa, Mylan, Sun Pharm Inds, Akorn, Wyeth Ayerst, Marsam Pharms Llc, Sun Pharm Inds Inc, Mylan Institutional, Alpharma Us Pharms, Heritage Pharma, Tris Pharma Inc, Bristol Myers Squibb, Strides Pharma, Watson Labs Inc, Amneal Pharms Ny, Ani Pharms, Amneal Pharms, Kv Pharm, Nostrum Labs Inc, Whiteworth Town Plsn, Usl Pharma, Zydus Pharms Usa, and Altana, and is included in eighty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for promethazine hydrochloride. Sixty-seven suppliers are listed for this compound.

Summary for Generic Name: promethazine hydrochloride

Tradenames:13
Patents:0
Applicants:52
NDAs:87
Drug Master File Entries: see list12
Suppliers / Packagers: see list67
Bulk Api Vendors: see list65
Clinical Trials: see list2,314
Patent Applications: see list2,667
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:promethazine hydrochloride at DailyMed

Pharmacology for Ingredient: promethazine hydrochloride

Ingredient-typePhenothiazines
Drug ClassPhenothiazine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro
PROMETHAZINE HYDROCHLORIDE
promethazine hydrochloride
SUPPOSITORY;RECTAL040603-001Oct 26, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Abbott
PROMETHAZINE HYDROCHLORIDE
promethazine hydrochloride
TABLET;ORAL084166-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
G And W Labs
PROMETHAZINE HYDROCHLORIDE
promethazine hydrochloride
SUPPOSITORY;RECTAL040428-002Mar 31, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Able
PROMETHAZINE HYDROCHLORIDE
promethazine hydrochloride
TABLET;ORAL040558-002Jul 1, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
PHENERGAN
promethazine hydrochloride
INJECTABLE;INJECTION008857-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
PROMETHAZINE HYDROCHLORIDE
promethazine hydrochloride
INJECTABLE;INJECTION040471-001Nov 21, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
PROMETHAZINE HYDROCHLORIDE
promethazine hydrochloride
INJECTABLE;INJECTION083532-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Heritage Pharma
PROMETHAZINE HYDROCHLORIDE
promethazine hydrochloride
TABLET;ORAL040673-002Mar 5, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Hospira
PROMETHAZINE HYDROCHLORIDE
promethazine hydrochloride
INJECTABLE;INJECTION083838-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Kv Pharm
PROMETHAZINE HYDROCHLORIDE
promethazine hydrochloride
SYRUP;ORAL085388-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
QuintilesIMS
Harvard Business School
US Army
Queensland Health
AstraZeneca
Dow
Johnson and Johnson
Merck
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot